TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Eris Lifesciences Ltd ( (IN:ERIS) ) has shared an update.
Eris Lifesciences Ltd’s board has approved the acquisition of a 30% stake in its subsidiary, Swiss Parenterals Limited, by issuing over 2.3 million equity shares on a preferential basis. This strategic move aims to strengthen Eris Lifesciences’ control over its subsidiary, potentially enhancing its market position and operational capabilities.
More about Eris Lifesciences Ltd
Eris Lifesciences Ltd is a company operating in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of a wide range of pharmaceutical products. The company is known for its emphasis on branded formulations and has a significant presence in the Indian market.
Average Trading Volume: 4,221
Technical Sentiment Signal: Buy
Current Market Cap: 226.7B INR
See more data about ERIS stock on TipRanks’ Stock Analysis page.